Insulin-like Growth Factor 1 (IGF-1) is a hormone produced primarily in the liver, and its levels are influenced by growth hormone. In dogs, as in other mammals, IGF-1 is involved in regulating growth, cell development, and metabolism. It promotes cellular proliferation and has a significant role in tissue repair and regeneration. Research has suggested that elevated levels of IGF-1 may be associated with increased risks of certain age-related diseases, such as cancer, which can impact a dog’s longevity and overall health. In the context of canine longevity, understanding IGF-1 is crucial. Studies have indicated that manipulating IGF-1 levels might influence aging processes, leading to potential interventions through dietary adjustments or pharmacological approaches. For instance, caloric restriction has been shown to lower IGF-1 levels in various species, including dogs, which may help enhance lifespan and healthspan. As the field of geroscience continues to evolve, insights into IGF-1 could pave the way for innovative strategies aimed at extending the healthy years of our beloved canine companions.
GLOSSARY
IGF-1
IGF-1, or Insulin-like Growth Factor 1, is a hormone that plays a key role in growth and development, influencing aging processes in dogs.
Why it matters
Monitoring IGF-1 levels can provide insights into your dog's growth, health risks, and potential strategies for promoting a longer, healthier life.
Tell us your dog's breed for personalized news
We email when there is real news, not before.
Keep exploring
newsPre-launch dossier: what we know about the canine longevity pill in 2026newsGeroscience consortium adds three more breeds to dose-finding studycountryPill watch: PortugalbreedPortuguese Sheepdog longevity briefnewsEU agency confirms it will publish a guidance document this quarterblogHow rapamycin moved from research curiosity to canine cliniccountryPill watch: IsraelblogThe geography of veterinary geroscience: who's leading, who's catching upglossaryGlossary: p53glossaryGlossary: OsteosarcomaglossaryGlossary: OsteoarthritisblogWhy insurance preauthorization for the pill will be the next battleground